Usefulness of C-reactive protein in the therapeutic follow-up of infected patients;Utilité de la C-reactive protein dans le suivi thérapeutique des patients infectés

Medecine et Maladies Infectieuses

Volumn 39, Issue 5, 2009, Pages 319-324

  Roger, P M ^a   Hung, S ^a   de Salvador, F ^a   Allieri Rosenthal, A ^b   Farhad, R ^a   Pulcini, C ^a   Cua, E ^a  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^b UNIVERSITY HOSPITAL OF NICE   (France)

Author keywords

Antibiotic therapy; CRP; Infection; Inflammation

Indexed keywords

ANTIBIOTIC AGENT; C REACTIVE PROTEIN;

AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BODY TEMPERATURE; CELLULITIS; COMORBIDITY; FEMALE; FOLLOW UP; GASTROINTESTINAL INFECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; RESPIRATORY TRACT INFECTION; URINARY TRACT INFECTION;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTEREMIA; BIOLOGICAL MARKERS; BODY TEMPERATURE; C-REACTIVE PROTEIN; FEMALE; FEVER; HUMANS; INFECTION; MALE; MIDDLE AGED; RESPIRATORY TRACT INFECTIONS; URINARY TRACT INFECTIONS;

EID: 67349281930     PISSN: 0399077X     EISSN: 17696690     Source Type: Journal    
DOI: 10.1016/j.medmal.2009.03.001     Document Type: Article

References (26)

1. Dellinger R.P., Levy M.M., Carlet J.M., et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock. Intensive Care Med 34 (2008) 17-60
2. Eriksson H., Svärdsudd K., Larsson B., Welin L., Ohlson L.O., Wilhelmsen L., et al. Temperature in general population samples. The study of men born in 1913 and 1923. Acta Med Scand 217 (1985) 347-352
3. Darowski A., WeinbergJR, and Guz A. A normal rectal, auditory canal, sublingual and axillary temperatures in elderly afebrile patients in a warm environnement. Age Ageing 20 (1991) 113-119
4. Mari I., Pouchot J., and Vinceneux P. Mesure de la température en pratique quotidienne. Rev Med Interne 18 (1997) 30-36
5. Bernheim H.A., Block L.H., and Atkins E. Fever: pathogenesis, pathophysiology, and purpose. Ann Intern Med 91 (1979) 261-270
6. Müller B., Schuetz P., and Trampuz A. Circulating biomarkers as surrogates for bloodstream infections. Int J Antimicrob Agents S1 (2007) S16-23
7. Smith R.P., Lipworth B.J., Cree I.A., Spiers E.M., and Winter J.H. C-reactive protein. A clinical marker in community-acquired pneumonia. Chest 108 (1995) 1288-1291
8. Gabay C., and Kushner. Acute phase proteins and other systemic responses to inflammation. N Engl J Med 340 (1999) 448-454
9. Pepys M.B., and Hirschfield G.M. C-reactive protein: a critical update. J Clin Invest 111 (2003) 1805-1812
10. Povoa P., Almeida E., Moreira P., Fernandes A., Mealha R., Aragao A., et al. C-reactive protein as an indicator of sepsis. Intensive Care Med 24 (1998) 1052-1056
11. Suprin E., Camus C., Gacouin A., Le Tulzo Y., Lavoue S., Feuillu A., et al. Procalcitonin: a valuable indicator of infection in a medical ICU?. Intensive Care Med 26 (2000) 1232-1238
12. Hogarth M.B., Gallimore R., Savage P., Palmer A.J., Starr J.M., Bulpitt C.J., et al. Acute phase proteins, C-reactive protein and serum amyloid A protein, as pronostic markers in the elderly inpatient. Age Ageing 26 (1997) 153-158
13. Neumaier M., and Scherer M.A. C-reactive protein levels for early detection of postoperative infection after fracture surgery in 787 patients. Acta Orthop 79 (2008) 428-432
14. Lavrentieva A., Kontakiotis T., Lazaridis L., Tsotsolis N., Koumis J., Kyriazis G., et al. Inflammatory markers in patients with severe burn injury. What is the best indicator of sepsis?. Burns 33 (2007) 189-194
15. Ford E.S. Does exercise reduce inflammation? Physical activity and C-reactive protein among U.S. adults. Epidemiol 13 (2002) 561-568
16. Devlin J., Gough A., Huissoon A., Perkins P., Holder R., Reece R., et al. The acute phase and function in early rheumatoid arthritis. C-reactive protein levels correlate with functional outcome. J Rheumatol 24 (1997) 9-13
17. Kushner I. C-reactive protein in rheumatology. Arthritis Rheum 34 (1991) 1065-1068
18. Pepys M.B., and Berger A. The renaissance of C-reactive protein. BMJ 322 (2001) 4-5
19. Liuzzo G., Biasucci L.M., Gallimore J.R., Grillo R.L., Rebuzzi A.G., Pepys M.B., et al. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N Engl J Med 331 (1994) 417-424
20. Danesh J., Collins R., Appleby P., and Peto R. Association of fibrinogen, C-reactive protein, albumin or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA 279 (1998) 1477-1482
21. Yentis S.M., Soni N., and Sheldon J. C-reactive protein as an indicator of resolution of sepsis in the intensive care unit. Intensive Care Med 21 (1995) 602-605
22. Roger P.M., Farhad R., Leroux S., Rancurel S., Licari M., Bellissimo R., et al. Gestion de services, tarification à l'activité. Recherche clinique et évaluation des pratiques professionnelles : un même outil informatique. Med Mal Infect 38 (2008) 457-464
23. Clyne B., and Olshaker J.S. The C-reactive protein. J Emergency Med 17 (1999) 1019-1025
24. Coelho L., Póvoa P., Almeida E., Fernandes A., Mealha R., Moreira P., et al. Usefulness of C-reactive protein in monitoring the severe community-acquired pneumonia clinical course. Crit Care 11 (2007) R92
25. Luzzani A., Polati E., Dorizzi R., Rungatscher A., Pavan R., and Merlini A. Comparison of procalcitonin and C-reactive protein as markers of sepsis. Crit Care Med 31 (2003) 1737-1741
26. Carboni G.L., Fahrner R., Gazdhar A., Printzen G., Schmid R.A., and Hoksch B. Comparison of procalcitonin and CrP in the postoperative course after lung decortication. Eur J Cardiothorac Surg 33 (2008) 777-780